https://orcid.org/0000-0002-4196-2893
References
- Walter JT, Alviña K, Womack MD, et al. Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia. Nat Neurosci. 2006;9(3):389–397.
- Garden GA, La Spada AR. Intercellular (mis) communication in neurodegenerative disease. Neuron. 2012;73(5):886–901.
- Mallah K, Couch C, Borucki DM, et al. Anti-inflammatory and neuroprotective agents in clinical trials for CNS disease and injury: where do we go from here? Front Immunol. 2020;11:2021.
- Pertwee RG. Pharmacology of cannabinoid receptor ligands. Curr Med Chem. 1999;6(8):635–664.
- Rodríguez-Cueto C, et al. Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias. Br J Pharmacol. 2014;171(6):1472–1489.
- Patel S, Hillard CJ. Cannabinoid CB1 receptor agonists produce cerebellar dysfunction in mice. J Pharmacol Exp Ther. 2001;297(2):629–637.
- Wang X, Whalley BJ, Stephens GJ. The du2J mouse model of ataxia and absence epilepsy has deficient cannabinoid CB1 receptor-mediated signalling. J Physiol. 2013;591(16):3919–3933.
- Stephens GJ. Does modulation of the endocannabinoid system have potential therapeutic utility in cerebellar ataxia? J Physiol. 2016;594(16):4631–4641.
- Gibson GE, Blass JP. Oxidative metabolism and acetylcholine synthesis during acetylpyridine treatment. Neurochem Res. 1985;10(4):453–467.
- Schulz JB, Henshaw DR, Jenkins BG, et al. 3-Acetylpyridine produces age-dependent excitotoxic lesions in rat striatum. J Cereb Blood Flow Metab. 1994;14(6):1024–1029.
- Colin F, Manil J, Desclin J. The olivocerebellar system. I. Delayed and slow inhibitory effects: an overlooked salient feature of cerebellar climbing fibers. Brain Res. 1980;187(1):3–27.
- Abbassian H, Whalley BJ, Sheibani V, et al. Cannabinoid type 1 receptor antagonism ameliorates harmaline-induced essential tremor in rat. Br J Pharmacol. 2016;173(22):3196–3207.
- Shabani M, Larizadeh MH, Parsania S, et al. Profound destructive effects of adolescent exposure to vincristine accompanied with some sex differences in motor and memory performance. Can J Physiol Pharmacol. 2012;90(4):379–386.
- Shabani M, Hosseinmardi N, Haghani M, et al. Maternal exposure to the CB1 cannabinoid agonist WIN 55212-2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar purkinje neurons in rat offspring. Neuroscience. 2011;172:139–152.
- Shabani M, Larizadeh MH, Parsania S, et al. Evaluation of destructive effects of exposure to cisplatin during developmental stage: no profound evidence for sex differences in impaired motor and memory performance. Int J Neurosci. 2012;122(8):439–448.
- Dehghanian F, Kalantaripour TP, Esmaeilpour K, et al. Date seed extract ameliorates β-amyloid-induced impairments in hippocampus of male rats. Biomed Pharmacother. 2017;89:221–226.
- Kalantarip TP, Asadi-Shek M, Basiri M, et al. Cerebroprotective effect of date seed extract (phoenix dactylifera) on focal cerebral ischemia in male rats. J of Biological Sciences. 2012;12(3):180–185.
- Morton SM, Bastian AJ. Cerebellar control of balance and locomotion. Neuroscientist. 2004;10(3):247–259.
- Duvick L, Barnes J, Ebner B, et al. SCA1-like disease in mice expressing wild-type ataxin-1 with a serine to aspartic acid replacement at residue 776. Neuron. 2010;67(6):929–935.
- Ebner BA, Ingram MA, Barnes JA, et al. Purkinje cell ataxin-1 modulates climbing fiber synaptic input in developing and adult mouse cerebellum. J Neurosci. 2013;33(13):5806–5820.
- Furrer SA, Waldherr SM, Mohanachandran MS, et al. Reduction of mutant ataxin-7 expression restores motor function and prevents cerebellar synaptic reorganization in a conditional mouse model of SCA7. Hum Mol Genet. 2013;22(5):890–903.
- Kawamura Y, Fukaya M, Maejima T, et al. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci. 2006;26(11):2991–3001.
- Smeets CJ, Verbeek DS. Climbing fibers in spinocerebellar ataxia: a mechanism for the loss of motor control. Neurobiol Dis. 2016;88:96–106.
- Ma Y-L, Weston SE, Whalley BJ, et al. The phytocannabinoid Δ9-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum. Br J Pharmacol. 2008;154(1):204–215.